Enzo Biochem, Inc.
ENZB
$0.4899
-$0.0001-0.02%
OTC PK
| 01/31/2025 | 10/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 18.04% | -17.45% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 18.04% | -17.45% | |||
| Cost of Revenue | -9.76% | -8.66% | |||
| Gross Profit | 66.01% | -29.19% | |||
| SG&A Expenses | -8.09% | 1.17% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -9.14% | -3.49% | |||
| Operating Income | 55.77% | -35.91% | |||
| Income Before Tax | 59.36% | -167.51% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 59.36% | -167.51% | |||
| Earnings from Discontinued Operations | 5.90% | 97.51% | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 54.53% | 74.77% | |||
| EBIT | 55.77% | -35.91% | |||
| EBITDA | 61.13% | -45.70% | |||
| EPS Basic | 54.49% | 75.30% | |||
| Normalized Basic EPS | 59.40% | -171.85% | |||
| EPS Diluted | 58.00% | 73.23% | |||
| Normalized Diluted EPS | 59.40% | -171.85% | |||
| Average Basic Shares Outstanding | 0.10% | 2.64% | |||
| Average Diluted Shares Outstanding | 0.10% | 2.64% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||